1 Discount Has One Big Catch: Some Sick Patients Don't Qualify

Key Points:

• Medicare launched an 18-month pilot program called the Bridge program to offer GLP-1 weight loss medications to some enrollees for $50 a month, aiming to improve affordability and assess potential long-term savings.
• Eligibility for the program requires Medicare Part D enrollment and a BMI of 35 or higher, or a BMI of 27-34 with certain health conditions; however, patients with FDA-approved GLP-1 treatable conditions like Type 2 diabetes or severe sleep apnea are excluded from the discounted pricing.
• Jeff La Marca, a 68-year-old with morbid obesity and severe sleep apnea, was denied the Bridge program despite qualifying by weight, as his sleep apnea diagnosis excluded him, leaving him to face high copays under standard Medicare Part D coverage.
• The pilot program has processed most prior authorizations quickly and enabled thousands to access GLP-1s at lower costs, but critics note it leaves out many with significant medical needs who still face high out-of-pocket expenses and complex approval processes.
• Experts estimate that millions qualify for the program, with potential Medicare costs ranging from $3.3 billion to $10 billion depending on enrollment, and expanding coverage further could increase costs substantially, highlighting ongoing challenges balancing affordability and access.